US 12,366,551

Application 17/665,427 · Granted Jul 22, 2025

Capillary electrophoresis system

Estimated expiration

August 27, 2032

5y 280d remaining

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
Earliest effective filing
Apr 13, 2011
+ 20 years
Apr 13, 2031
PTA +502d
Aug 27, 2032
No TD
—
Final
Aug 27, 2032

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.

Calculation details

Base term

Filing date
February 4, 2022
Earliest effective filing
April 13, 2011
Issue date
July 22, 2025
PTA
+502 days
Base expiry (before PTA)
April 13, 2031

April 13, 2011 + 20 years = April 13, 2031 + 502 PTA days = August 27, 2032

  • Divisional of application 15/677,535, filed Aug 15, 2017, issued as US 11,340,191
  • Continuation-in-part of application 14/822,956, filed Aug 11, 2015
  • Continuation of application 13/470,870, filed May 14, 2012, issued as US 9,140,666
  • Continuation-in-part of application 29/421,549, filed Mar 15, 2012, issued as US D689,621
  • Continuation-in-part of application 29/389,556, filed Apr 13, 2011
  • Continuation-in-part of application 29/421,549, filed Mar 15, 2012, issued as US D689,621
  • Continuation of application 13/470,870, filed May 14, 2012, issued as US 9,140,666
  • Continuation-in-part of application 29/421,549, filed Mar 15, 2012, issued as US D689,621
  • Continuation-in-part of application 14/822,956, filed Aug 11, 2015
  • Continuation of application 13/470,870, filed May 14, 2012, issued as US 9,140,666
  • Continuation-in-part of application 29/421,549, filed Mar 15, 2012, issued as US D689,621
  • PRO61/643,411 — Provisional — not used for base term
  • PRO61/643,411 — Provisional — not used for base term
  • PRO61/643,411 — Provisional — not used for base term
  • PRO61/643,411 — Provisional — not used for base term

Terminal disclaimers

No TD0 approved, 0 filed

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 17/665,427 · US 12,366,551

PatentReply compiles the prosecution history behind US 12,366,551: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US12366551

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.